Eltanexor

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Eltanexor (KPT-8602) is an experimental drug which is a selective inhibitor of nuclear export (SINE), acting as a selective inhibitor of the XPO1 nuclear export protein. Levels of this protein are frequently elevated in numerous forms of cancer, such as prostate cancer and multiple myeloma, and eltanexor has shown promising results in several clinical trials, mainly as a combination treatment with other drugs rather than a sole agent. It has also shown potential for the treatment of osteoporosis.

Eltanexor (KPT-8602) is an experimental drug which is a selective inhibitor of nuclear export (SINE), acting as a selective inhibitor of the XPO1 nuclear export protein. Levels of this protein are frequently elevated in numerous forms of cancer, such as prostate cancer and multiple myeloma, and eltanexor has shown promising results in several clinical trials, mainly as a combination treatment with other drugs rather than a sole agent. It has also shown potential for the treatment of osteoporosis.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1368651679 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.